DE3584179D1 - Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i. - Google Patents

Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i.

Info

Publication number
DE3584179D1
DE3584179D1 DE8585103060T DE3584179T DE3584179D1 DE 3584179 D1 DE3584179 D1 DE 3584179D1 DE 8585103060 T DE8585103060 T DE 8585103060T DE 3584179 T DE3584179 T DE 3584179T DE 3584179 D1 DE3584179 D1 DE 3584179D1
Authority
DE
Germany
Prior art keywords
insuline
producing
growth factor
growth
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585103060T
Other languages
English (en)
Inventor
Ikuo Ueda
Mineo Niwa
Yoshimasa Saito
Susumu Sato
Hiroki Ono
Tadashi Kitaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407044A external-priority patent/GB8407044D0/en
Priority claimed from GB848424197A external-priority patent/GB8424197D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3584179D1 publication Critical patent/DE3584179D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
DE8585103060T 1984-03-19 1985-03-16 Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i. Expired - Fee Related DE3584179D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407044A GB8407044D0 (en) 1984-03-19 1984-03-19 Producing human insulin
GB848424197A GB8424197D0 (en) 1984-09-25 1984-09-25 Production of insulin-like growth factor

Publications (1)

Publication Number Publication Date
DE3584179D1 true DE3584179D1 (de) 1991-10-31

Family

ID=26287470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585103060T Expired - Fee Related DE3584179D1 (de) 1984-03-19 1985-03-16 Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i.

Country Status (7)

Country Link
US (1) US5019500A (de)
EP (1) EP0155655B1 (de)
JP (2) JPH07108229B2 (de)
CA (1) CA1297813C (de)
DE (1) DE3584179D1 (de)
DK (1) DK108685A (de)
IL (1) IL74626A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US5242811A (en) * 1985-03-26 1993-09-07 Biogen, Inc. Production of human somatomedin C
GB8509289D0 (en) * 1985-04-11 1985-05-15 Fujisawa Pharmaceutical Co Production of somatostatin
DE3686365T3 (de) * 1985-06-20 2000-07-27 Fujisawa Pharmaceutical Co Herstellungsverfahren für humanes atriales natriuretisches Polypeptid.
EP0219814B1 (de) * 1985-10-21 1991-09-11 Fujisawa Pharmaceutical Co., Ltd. Verfahren zur Herstellung von insulinähnlichem Wachstumsfaktor I (IGF-I) und Plasmid zu dessen Herstellung
DE3636903A1 (de) * 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
US5496924A (en) * 1985-11-27 1996-03-05 Hoechst Aktiengesellschaft Fusion protein comprising an interleukin-2 fragment ballast portion
ES2044887T3 (es) * 1986-10-09 1994-01-16 Fujisawa Pharmaceutical Co Metodo para la preparacion de factor de crecimiento de tipo insulina i.
US5340725A (en) * 1986-10-09 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Expression vector for insulin-like growth factor I and method of production
ATE125869T1 (de) * 1989-06-09 1995-08-15 Gropep Pty Ltd Wachstumshormonfusionsproteine.
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
EP0578754B1 (de) * 1991-04-05 1995-06-07 The Upjohn Company TrpR MUTATIONEN DIE WIRKSAM SIND IN DER EXPRESSION VON KLEINEN PROTEINEN UND PEPTIDEN
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5371198A (en) * 1991-12-16 1994-12-06 Novo Nordisk A/S Method for protection of proteolysis-susceptible protein during protein production in a fluid medium
US5623059A (en) * 1992-03-09 1997-04-22 Novo Nordisk A/S Method for protection of proteolysis-susceptible protein during protein production in a fluid medium
IL104734A0 (en) * 1993-02-15 1993-06-10 Univ Bar Ilan Bioactive conjugates of cellulose with amino compounds
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
EP0779927A1 (de) * 1994-09-08 1997-06-25 Chiron Corporation Methode zur gesteigerten herstellung von insulin-ähnlichem wachstumsfaktor
US20030143695A1 (en) * 1999-12-17 2003-07-31 Shuji Hinuma Novel polypeptide and dna thereof
US20040096433A1 (en) * 2000-12-11 2004-05-20 Breier Bennett Hermann Heinrich Regulation of angiontensin II receptors in mammals subject to fetal programming
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO783724L (no) * 1977-11-08 1979-05-09 Genentech Inc Syntetisk dna samt fremgangsmaate til dets fremstilling
DK173092B1 (da) * 1977-11-08 2000-01-10 Genentech Inc Rekombinant plasmid, fremgangsmåde til fremstilling af plasmidet, bakterie indeholdende plasmidet, samt fremgangsmåde til f
IL60184A (en) * 1979-05-31 1984-05-31 Schering Ag Process for the specific cleavage of protein sequences from proteins
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
US4338144A (en) * 1980-03-24 1982-07-06 General Electric Company Method of producing silicon-iron sheet material with annealing atmospheres of nitrogen and hydrogen
CA1207253A (en) * 1981-08-17 1986-07-08 Lee D. Simon T4 dna fragment as a stabilizer for proteins expressed by cloned dna
US4571921A (en) * 1981-09-02 1986-02-25 Burr-Brown Corporation Expendable heater sealing process
DE3378638D1 (de) * 1982-10-25 1989-01-12 Monsanto Co Reca promoter dependent polypeptide production
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
EP0128042A3 (de) * 1983-06-06 1985-01-16 Genentech, Inc. Verfahren zur Identifizierung oder Isolierung einer DNS-Sequenz und eine dazu verwendete DNS-Hybridizierungsprobe
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
US4745179A (en) * 1984-04-02 1988-05-17 Fujisawa Pharmaceutical Co., Ltd. 59 Valine insulin-like growth factor I and process for production thereof

Also Published As

Publication number Publication date
EP0155655A2 (de) 1985-09-25
DK108685A (da) 1985-09-20
JPH05345797A (ja) 1993-12-27
DK108685D0 (da) 1985-03-08
JPH07108229B2 (ja) 1995-11-22
CA1297813C (en) 1992-03-24
IL74626A0 (en) 1985-06-30
JPH0713080B2 (ja) 1995-02-15
US5019500A (en) 1991-05-28
IL74626A (en) 1999-10-28
EP0155655A3 (en) 1987-09-16
JPH05292979A (ja) 1993-11-09
EP0155655B1 (de) 1991-09-25

Similar Documents

Publication Publication Date Title
DE3584179D1 (de) Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i.
DE3587442D1 (de) Verfahren zur herstellung von polysilsesquioxanen.
DE3583754D1 (de) Verfahren zur herstellung eines optischen speicherelements.
AT384022B (de) Verfahren zur herstellung von 1,2,4-triazol-3onen
DE3852026D1 (de) Verfahren zur herstellung eines elektrolytischen kondensators.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3585052D1 (de) Verfahren zur herstellung von l-isoleucin durch fermentation.
DE3586638T2 (de) Verfahren zur herstellung von vanadylphthalocyanin.
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
DE3575728D1 (de) Verfahren zur herstellung kristallisierten maltitols.
DE3868128D1 (de) Verfahren zur herstellung eines supraleitenden gegenstandes.
DE3878342D1 (de) Verfahren zur herstellung eines agglomerierten schleifmittels.
DE3582001D1 (de) Verfahren zur herstellung eines gleitkoerpers.
DE3575128D1 (de) Verfahren zur herstellung von 4-acetoxy-3-hydroxyethylazetizin-2-on derivaten.
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
DE3684430D1 (de) Verfahren zur herstellung eines bildes.
DE3583818D1 (de) Verfahren zur herstellung eines cyclischen alkohols.
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.
DE3880640T2 (de) Verfahren zur herstellung aliphatischer o-arylurethane.
DE3687954D1 (de) Verfahren zur herstellung eines tetraalkoxysilans.
DE3584754D1 (de) Verfahren zur herstellung von arylalkylketonen.
DE3581971D1 (de) Verfahren zur herstellung eines oligopeptids.
DE3581667D1 (de) Verfahren zur herstellung von 5-deoxy-l-arabinose.
DE3584056D1 (de) Verfahren zur herstellung von thioaether(bisphthalimid).

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee